IA
TMO icon

IndexIQ Advisors’s Thermo Fisher Scientific TMO Stock Holding History

IndexIQ Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$7.28M Buy
12,318
+5,730
+87% +$3.29M 0.26% 81
2021
Q4 		$4.4M Sell
6,588
-227
-3% -$142K 0.15% 109
2021
Q3 		$3.89M Buy
6,815
+335
+5% +$184K 0.13% 123
2021
Q2 		$3.27M Buy
6,480
+138
+2% +$65.1K 0.11% 166
2021
Q1 		$2.89M Sell
6,342
-5,870
-48% -$2.8M 0.1% 195
2020
Q4 		$5.69M Buy
12,212
+2,592
+27% +$1.22M 0.21% 73
2020
Q3 		$4.25M Buy
9,620
+1,738
+22% +$718K 0.17% 75
2020
Q2 		$2.86M Buy
7,882
+813
+12% +$273K 0.13% 96
2020
Q1 		$2M Sell
7,069
-8,321
-54% -$2.62M 0.09% 116
2019
Q4 		$5M Buy
15,390
+3,428
+29% +$1.04M 0.18% 99
2019
Q3 		$3.48M Sell
11,962
-4,105
-26% -$1.18M 0.12% 130
2019
Q2 		$4.72M Sell
16,067
-385
-2% -$106K 0.14% 114
2019
Q1 		$4.5M Buy
+16,452
New +$4.09M 0.13% 94

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IndexIQ Advisors's TMO Position: Q1 2022 in Review

IndexIQ Advisors increased its Thermo Fisher Scientific (TMO) stake by 87% in Q1 2022, buying an estimated $3.29M and bringing the position to 12,318 shares worth $7.28M. The position accounts for 0.26% of the portfolio, ranked #81.

IndexIQ Advisors first reported a position in TMO in Q1 2019 and has held it in 13 quarters since. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • IndexIQ Advisors held 12,318 shares of Thermo Fisher Scientific worth $7.28M as of Q1 2022.
  • IndexIQ Advisors bought 5,730 Thermo Fisher Scientific shares in Q1 2022, an estimated $3.29M.
  • Thermo Fisher Scientific made up 0.26% of IndexIQ Advisors's portfolio in Q1 2022, its #81 holding.
  • IndexIQ Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 13 quarters since.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.